An emerging role for LRRK2 in the immune system

Download files
Access & Terms of Use
open access
Abstract
Missense mutations in leucine-rich repeat kinase 2 (LRRK2) contribute significantly to autosomal dominant Parkinson’s disease (PD). Genome-wide association studies have further suggested that mutations in LRRK2 comprise a risk factor for sporadic PD. How LRRK2 contributes to PD however, is largely unknown. Recent work has shown that LRRK2 is highly expressed in tissue and circulating immune cells and is suggestive of a potential role for LRRK2 in innate immunity. These studies and their potential implications for PD will be discussed.
Persistent link to this record
DOI
Link to Publisher Version
Additional Link
Author(s)
Dzamko, Nicolas
Halliday, Glenda
Supervisor(s)
Creator(s)
Editor(s)
Translator(s)
Curator(s)
Designer(s)
Arranger(s)
Composer(s)
Recordist(s)
Conference Proceedings Editor(s)
Other Contributor(s)
Corporate/Industry Contributor(s)
Publication Year
2012
Resource Type
Journal Article
Degree Type
UNSW Faculty
Files
download 2012_Dzamko_BST.pdf 316.07 KB Adobe Portable Document Format
Related dataset(s)